Combined Effects of Buteyko Breathing Technique and Chest Wall Mobilization on Pulmonary Functions and Quality of Life

NCT ID: NCT06537479

Last Updated: 2024-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-06-13

Study Completion Date

2024-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to evaluate the effects of Buteyko breathing techniques with and without chest wall mobilization on pulmonary functions, and quality of life in chronic smokers. The study design will be a randomized clinical trial. The study will be completed in 10 months after the approval of the synopsis from the Ethical Committee of RCRS \& AHS. A non-probability convenient sampling technique will be used to recruit the individuals. Group 1-Buteyko breathing technique + Chest Wall Mobilization and Group 2-Buteyko Breathing Technique + Without Chest Wall Mobilization

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized clinical trial will evaluate the combined effect of the Buteyko breathing technique and chest wall mobilization on pulmonary functions and quality of life in chronic smokers. A sample size of 40 is calculated through a non-probability convenient sampling technique. Participants will be recruited into Group 1 and Group 2 by lottery method (without replacement). Group 1 will be engaged in the Buteyko breathing technique + Chest Wall Mobilization and Group 2 will undergo Buteyko Breathing Technique + Without Chest Wall Mobilization. Pre and post-outcome measures of pulmonary functions will be measured through a digital spirometer and quality of life will be assessed by the St George Quality of Life Questionnaire.

Spirometry assesses the amount and speed of air that can be inhaled and exhaled. Key measurements include Forced Vital Capacity (FVC): The maximum volume of air forcefully exhaled after a full inhalation. Forced Expiratory Volume in 1 Second (FEV1): The volume of air exhaled in the first second of the FVC test, indicates how quickly the lungs can be emptied.

St Saint Georg quality of life questionnaire for assessing the QOL. The SGRQ is a standardized self-administered airway disease-specific questionnaire divided into 2 subscales, a total of 12 questions. For each subscale and the overall questionnaire, scores range from zero (no impairment) to 100 (maximum impairment).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Smokers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Buteyko breathing technique, Chest wall mobilization

Deep breathing exercises for 5 minutes. After the 5-minute resting interval Buteyko breathing technique and chest wall mobilization of 5 minutes Chest wall mobilization with 8-10 repetitions. Total time duration will be 30 minutes. 2 sessions per week

Group Type EXPERIMENTAL

Buteyko breathing technique

Intervention Type OTHER

Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.

Chest Wall Mobilization

Intervention Type OTHER

It started with positioning, sitting or standing with good posture, and relaxing shoulders and arms. Hands were placed on the chest with fingers wide and thumbs on side of ribcage. Inhale deep breaths with expansion of chest and hands move outward. Exhale slowly allowed the chest to drop and the hands to move inward.

Buteyko breathing technique

Deep breathing for 5 minutes as a baseline Buteyko technique of 2 sets of 8-10 repetitions for 2 days a week. Chest wall mobilization will not be included in Group 2. Repeat the breathing cycle for 5-10 minutes, 2-3 times a day. Total time duration will be 30 minutes.

Group Type ACTIVE_COMPARATOR

Buteyko breathing technique

Intervention Type OTHER

Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Buteyko breathing technique

Participants will be advised to sit in a comfortable and relaxed position and take a shallow breath through nose, partially filling the lungs. Hold breath for 2-3 seconds and exhale slowly through the nose and emptying the lungs.

Intervention Type OTHER

Chest Wall Mobilization

It started with positioning, sitting or standing with good posture, and relaxing shoulders and arms. Hands were placed on the chest with fingers wide and thumbs on side of ribcage. Inhale deep breaths with expansion of chest and hands move outward. Exhale slowly allowed the chest to drop and the hands to move inward.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both male and female participants were included
* The age of participants was 40 -55 years.
* Individuals who fulfilled the criteria of smoking which is calculated by multiplying the number of packs smoked per day by the number of years smoked were included.
* Individuals who are current smokers or history of long-term smoking were included.
* Predicted values FEV1 \< 75% and FEV1/FVC \<70%

Exclusion Criteria

* Participants with neurological disorders were excluded
* Participants with musculoskeletal disorders were excluded as it affects the physical activity of the 6-minute walk test.
* Participants having any pulmonary complications or lung disease were excluded.
* Participants previously involved in any other exercise or physical activity were excluded.
Minimum Eligible Age

40 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tasneem Shehzadi, Mphil

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Lahore Teaching Hospital

Lahore, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kinza Saleem, DPT

Role: CONTACT

03067639002

Tasneem Shahzadi, TDPT

Role: CONTACT

03104108327

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Samia Sarmad, PHD

Role: primary

03004813195

Jawad, MS-NMPT

Role: backup

03124047465

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR & AHS/23/0373

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.